Klaus Mantwill
Ismaninger Str, 22
Munich, BY 81675, Germany
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Integration of a multimeric STAT consensus site into the adenoviral genome to interfere with IFN signaling represents a novel concept to improve oncolytic virotherapy.
Journal: Journal of virology
Published: August 10, 2026
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer.
Journal: Scientific reports
Published: November 25, 2024
Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 06, 2023
Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
Journal: Journal of virology
Published: May 23, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 12, 2022
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.
Journal: International journal of molecular sciences
Published: August 04, 2022
Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer.
Journal: Urologic oncology
Published: July 13, 2022
Concepts in Oncolytic Adenovirus Therapy.
Journal: International journal of molecular sciences
Published: August 27, 2021
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Journal: Nature communications
Published: May 28, 2021
The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.
Journal: Human gene therapy
Published: June 20, 2018
Adenovirus Particle Quantification in Cell Lysates Using Light Scattering.
Journal: Human gene therapy methods
Published: August 16, 2017
An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Journal: Cancer gene therapy
Published: July 23, 2014
Last Updated: 09/26/2026